Organon Denmark ApS: Financial statements 2020
CVR: 41193093
Source: annual report 2020, Danish Business Authority
24/02/2020 – 31/12/2020
Organon Denmark ApS (CVR 41193093) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 49,240,000 and a net result of DKK 1,338,000. The profit margin was 2.7%. Equity in the 2020 report amounted to DKK 22,666,000. The solvency ratio was 36%. The company had 5 employees in the financial year.
- Revenue
- DKK 49,240,000
- Gross Profit
- DKK 4,382,000
- Profit/Loss
- DKK 1,338,000
- Equity
- DKK 22,666,000
- Total Assets
- DKK 62,896,000
- Employees
- 5
Official annual report
How creditworthy is Organon Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of November 3, 2020, is registered as an owner of Organon Denmark ApS with an ownership share of 100%.
On May 6, 2020, the company changed its name from OBS Denmark ApS to Organon Denmark ApS.
As of February 24, 2020, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Organon Denmark ApS.
As of February 24, 2020, Andreas Daugaard Jørgensen is registered as director of Organon Denmark ApS.
As of February 24, 2020, Torstein Ljøkjel Erskov Winterstø is registered as director of Organon Denmark ApS.
As of February 24, 2020, Funda Zeynep Ekincioglu is registered as director of Organon Denmark ApS.
Organon Denmark ApS was founded on February 24, 2020.
About Organon Denmark ApS
Organon Denmark ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named OBS Denmark ApS. The management consists of Anne Bitzer, Karl Johan Sundt and Sofia Raquel Paulos Ferreira Alves da Silva. The company is owned by OBS Human Health Holding B.V.. The company has 6 employees (2026). In 2025, the company reported revenue of DKK 61,554,000 and a net result of DKK 3,139,000 compared with DKK 2,428,000 the year before. Equity in the 2025 report amounted to DKK 31,049,000.